ACTRN12608000365369Recruiting未知
A randomised double blind placebo controlled trial of radiofrequency neurotomy for the treatment of lumbar zygapophysial joint pain
Dr. Paul Verrills0 sites30 target enrollmentStarted: July 25, 2008Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 30
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomised controlled trial
- Primary Purpose
- Treatment
- Masking
- Blinded (masking used)
Eligibility Criteria
- Ages
- 18 Years to o limit (—)
- Sex
- All
Inclusion Criteria
- •1. Low back pain for a duration of more than 3 months
- •2. Pain severity of at least 5/10 on a visual analogue scale, which is sufficient to warrant invasive treatment
- •3. Complete, or vitually complete, relief of pain in response to controlled, medial branch blocks performed on at least two occasions.
- •4. Up to, but not exceeding two sympathetic zygapophysial joints per side
Exclusion Criteria
- •1. Unable to provide informed consent
- •2. Unable to complete the assessment instruments
- •3. Anatomical abnormalities that might interfere with the safe conduct of the treatment
- •4. Any illness or disorder that might interfere with the safe conduct of treatment
- •5. Overt, clinically evident psychological disturbance, such as severe depression, drug dependence, or drug-seeking behaviour that might interfere with the assessment or response to treatment
- •6. Concomitant cervical, thoracic, hip, or other pain, of an intensity greater than 2/10 (on the visual analogue scale (VAS))or otherwise, which may interfere with the assessment or response to treatment
Investigators
Similar Trials
Not yet recruiting
Phase 2
A randomised controlled trial of a novel combination pharmacotherapy program for the treatment of cannabis dependencecannabis dependenceMental Health - AddictionACTRN12609000581268St Vincents, Melbourne120
Completed
Not Applicable
A randomised double blind placebo controlled trial of the addition of metformin to optimal treatment in patients with chronic heart failure. Assessment by regional haemodynamics neurohumoral activation and symptomatic well beingCardiovascular: Congestive heart failure (CHF)Circulatory SystemHeart failureISRCTN22334267Department of Health (UK)20
Not yet recruiting
Phase 3
Intravenous lidocaine in the prevention of postoperative ileusPost operative ileusACTRN12618000123246niversity of Otago, Christchurch140
Completed
Phase 2
ew Zealand Eplerenone Aortic Stenosis TrialCardiovascular - Other cardiovascular diseasesAortic stenosisACTRN12606000125527Pfizer (Investigator initated trial conducted independently of sponsor)66
Completed
Phase 3
A randomised double blind placebo controlled trial of infusional subcutaneous octreotide in the management of malignant bowel obstruction at the end of life.Bowel obstruction in the setting of advanced cancerCancer - Other cancer typesACTRN12608000211369Flinders University94